Stock CELSION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Celsion Corporation Nasdaq

Equities

US15117N3052

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Celsion Corporation
24/06 Imunon, Inc. Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer CI
05/06 IMUNON, Inc. Announces First Participants Vaccinated in IMNN-101 Phase 1 Clinical Trial CI

Chart calendar Celsion Corporation

f3cdfa189093b75023e63a3f2f54.WxW5gvZGwgQejL6zhtp6AEMF_pTxOtna2qWGJ-8GvJI.FlSAr7EjpzFt7Yv08IpMUzlQ08uLDeCJlNbtZd8w-b8DItrxryj2W3bj1Q~59a1470e5d0680d0c0b28c86cded393c

Upcoming events on Celsion Corporation

14/08/2024 Q2 2024 Earnings Release (Projected)
11/11/2024 Q3 2024 Earnings Release (Projected)
27/03/2025 Q4 2024 Earnings Release (Projected)
19/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Celsion Corporation

12/06/2024 Annual General Meeting
03/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract No. TPS5633
13/05/2024 08:30 pm Q1 2024 Earnings Call
13/05/2024 05:30 pm Q1 2024 Earnings Release
28/03/2024 07:30 pm Q4 2023 Earnings Call
28/03/2024 05:30 pm Q4 2023 Earnings Release
14/11/2023 08:30 pm Q3 2023 Earnings Call
14/11/2023 06:30 pm Q3 2023 Earnings Release
23/10/2023 11:30 pm Edition of International Vaccines Congress
15/09/2023 01:30 am R&D Day
11/09/2023 04:30 pm H.C. Wainwright Global Investment Conference
10/08/2023 08:30 pm Q2 2023 Earnings Call
10/08/2023 05:30 pm Q2 2023 Earnings Release
14/06/2023 07:30 pm Annual General Meeting
13/06/2023 Mass General Brigham World Medical Innovation Forum
21/05/2023 Viruses and Cells Gordon Research Conference
11/05/2023 08:30 pm Q1 2023 Earnings Call
11/05/2023 05:30 pm Q1 2023 Earnings Release
18/04/2023 06:30 pm American Association for Cancer Research Meeting - Abstract No. 4440
30/03/2023 08:30 pm Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,50
0,51
-0.99%		0,50
0,50
0%		0,50
0,50
0%		0,50
0,50
0%		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-20,6
-21,3
3.29%		-18,5
-18,1
-2.32%		-21,0
-21,1
0.4%		-24,9
-24,4
-1.98%		-21,0
-20,7
-1.62%
-21,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-18,7
-20,6
9.5%		-23,3
-23,3
-0.08%		-22,2
-22,2
0.14%		-37,5
-28,9
-29.6%		-20,8
-20,2
-3.17%
-21,7

Net income
Million USD		Released
Forecast
Spread 		-16,9
-19,6
13.92%		-21,5
-23,3
7.83%		-20,8
-22,2
6.38%		-35,9
-28,6
-25.48%		-19,5
-20,2
3.18%
-21,2

EPS
USD		Released
Forecast
Spread 		-11,5
-14,0
17.65%		-10,0
-10,9
8.22%		-3,83
-4,05
5.43%		-5,03
-4,19
-20.19%		-2,16
-2,23
3.28%
-2,09

Announcement Date25/03/2019/03/2131/03/2230/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,13
0,11
15.39%		0,13
0,11
15.39%		0,13
0,11
11.11%		0,13
0,11
11.11%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-5,84
-5,69
-2.66%		-5,98
-5,95
-0.53%		-6,17
-6,03
-2.47%		-6,93
-6,44
-7.55%		-5,68
-6,30
9.78%		-5,47
-6,27
12.73%		-3,90
-6,05
35.51%		-5,97
-5,61
-6.42%		-5,01
-5,36
6.49%
-5,27


-5,30


-5,76

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-10,5
-5,85
-79.09%		-6,04
-5,92
-2.08%		-6,15
-6,00
-2.47%		-14,8
-6,29
-135.12%		-5,59
-6,30
11.25%		-5,56
-6,28
11.47%		-3,48
-6,13
43.25%		-6,17
-5,55
-11.18%		-4,93
-5,43
9.15%
-5,34


-5,20


-5,76

Net income
Million USD		Released
Forecast
Spread 		-10,5
-5,85
-79.09%		-6,04
-5,92
-2.08%		-6,15
-6,00
-2.47%		-13,2
-6,48
-104.24%		-5,59
-6,30
11.25%		-5,56
-6,28
11.47%		-3,48
-6,13
43.25%		-4,89
-5,55
11.9%		-4,93
-5,43
9.15%
-5,34


-5,20


-5,76

EPS
USD		Released
Forecast
Spread 		-1,82
-1,01
-81.09%		-0,87
-0,98
11.22%		-0,87
-0,81
-7.41%		-1,61
-0,84
-92.24%		-0,68
-0,69
1.45%		-0,61
-0,73
16.82%		-0,37
-0,66
43.94%		-0,52
-0,59
11.36%		-0,52
-0,57
8.24%
-0,55


-0,53


-0,49

Announcement Date16/05/2215/08/2214/11/2230/03/2311/05/2310/08/2314/11/2328/03/2413/05/24---

Upcoming sector events for Celsion Corporation

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 EXELIXIS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Celsion Corporation

12/07/2024 01:30 am NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release
09/07/2024 LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release
08/07/2024 TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release
05/07/2024 PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release
07/06/2024 LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release
07/06/2024 TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release
05/06/2024 01:21 pm PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. IMNN Stock
  4. Stock
  5. Calendar Celsion Corporation